{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:45:24Z","timestamp":1791042324255,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1378\/chest.12-1246","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T03:31:07Z","timestamp":1372735867000},"page":"274-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Biomarkers in Pulmonary Hypertension"],"prefix":"10.1016","volume":"144","author":[{"given":"Vasile","family":"Foris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tscherner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1378\/chest.12-1246_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 1","key":"10.1378\/chest.12-1246_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0167-5273(11)70488-0","article-title":"Non-invasive diagnosis of pulmonary hypertension: ESC\/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011","volume":"154","author":"Gr\u00fcnig","year":"2011","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1378\/chest.12-1246_bib3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8","year":"2009","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.12-1246_bib4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1183\/09031936.93.03080910","article-title":"Atrial natriuretic peptide in primary pulmonary hypertension","volume":"3","author":"Morice","year":"1990","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.12-1246_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s003920050016","article-title":"Oxygen-mediated pulmonary vasodilation and plasma levels of endothelin-1, atrial natriuretic peptide and cyclic GMP in patients with left-to-right shunt and pulmonary hypertension","volume":"89","author":"Gorenflo","year":"2000","journal-title":"Z Kardiol"},{"issue":"4","key":"10.1378\/chest.12-1246_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0735-1097(01)01490-5","article-title":"Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation","volume":"38","author":"Wiedemann","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1378\/chest.12-1246_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1378\/chest.12-1246_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1183\/09031936.00070209","article-title":"Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension","volume":"35","author":"Sztrymf","year":"2010","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1378\/chest.12-1246_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.amjcard.2009.11.041","article-title":"Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease","volume":"105","author":"Giannakoulas","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1378\/chest.12-1246_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0003-4975(02)03654-8","article-title":"Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy","volume":"74","author":"Nagaya","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"23","key":"10.1378\/chest.12-1246_bib11","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.12-1246_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1378\/chest.12-1246_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"issue":"11","key":"10.1378\/chest.12-1246_bib14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.amjcard.2011.07.025","article-title":"Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension","volume":"108","author":"Mauritz","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1378\/chest.12-1246_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/2045-8932.83450","article-title":"Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension","volume":"1","author":"Soon","year":"2011","journal-title":"Pulm Circ"},{"issue":"18","key":"10.1378\/chest.12-1246_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.12-1246_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0735-1097(88)90282-3","article-title":"Verapamil impairs secretion of stimulated atrial natriuretic factor in humans","volume":"11","author":"Haufe","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1378\/chest.12-1246_bib18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.0000084544.54513.E2","article-title":"Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension","volume":"108","author":"Torbicki","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1378\/chest.12-1246_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/CS20100014","article-title":"High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension","volume":"119","author":"Filusch","year":"2010","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1378\/chest.12-1246_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","article-title":"Hyperuricaemia in patients with right or left heart failure","volume":"13","author":"Hoeper","year":"1999","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.12-1246_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.117.1.19","article-title":"Hyperuricemia in severe pulmonary hypertension","volume":"117","author":"Voelkel","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.12-1246_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","article-title":"Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension","volume":"160","author":"Nagaya","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-1246_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1183\/09031936.00134506","article-title":"Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension","volume":"29","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-1246_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.00100407","article-title":"Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension","volume":"31","author":"Lankeit","year":"2008","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-1246_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201001-0007OC","article-title":"Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension","volume":"182","author":"Heresi","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1378\/chest.12-1246_bib26","first-page":"904","article-title":"Unrecognized glucose intolerance is common in pulmonary arterial hypertension","volume":"30","author":"Pugh","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1378\/chest.12-1246_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1378\/chest.11-1267","article-title":"Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension","volume":"142","author":"Cracowski","year":"2012","journal-title":"Chest"},{"key":"10.1378\/chest.12-1246_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-10-22","article-title":"Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension","volume":"10","author":"Takeda","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1378\/chest.12-1246_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.124.4.1305","article-title":"Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension","volume":"124","author":"Sakamaki","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.12-1246_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1160\/TH03-02-0067","article-title":"High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension","volume":"90","author":"Bonderman","year":"2003","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1378\/chest.12-1246_bib31","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1161\/01.CIR.96.9.2782","article-title":"Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension","volume":"96","author":"Friedman","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.12-1246_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2009.04.018","article-title":"Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension","volume":"125","author":"Maeda","year":"2010","journal-title":"Thromb Res"},{"issue":"2","key":"10.1378\/chest.12-1246_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/rheumatology\/keg071","article-title":"Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension","volume":"42","author":"Jinnin","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"14","key":"10.1378\/chest.12-1246_bib34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2008.12.038","article-title":"C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension","volume":"53","author":"Quarck","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"41-42","key":"10.1378\/chest.12-1246_bib35","first-page":"573","volume":"137","author":"Ulrich","year":"2007","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1378\/chest.12-1246_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjcard.2009.05.016","article-title":"Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension","volume":"104","author":"Hampole","year":"2009","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1378\/chest.12-1246_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2011.02.057","article-title":"Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights","volume":"58","author":"Rhodes","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1378\/chest.12-1246_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.2003.020040","article-title":"Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers","volume":"64","author":"Allanore","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1378\/chest.12-1246_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.0000139859.68513.FC","article-title":"Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells","volume":"110","author":"Dam\u00e5s","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.12-1246_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3899\/jrheum.080542","article-title":"Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue diseases","volume":"36","author":"Cella","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.12-1246_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1164\/rccm.200703-506OC","article-title":"Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation","volume":"177","author":"Otterdal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.12-1246_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.12-1246_bib43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1183\/09031936.00174908","article-title":"Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension","volume":"34","author":"Selimovic","year":"2009","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1378\/chest.12-1246_bib44","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-1246_bib45","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.10-1146","article-title":"Osteopontin in patients with idiopathic pulmonary hypertension","volume":"139","author":"Lorenzen","year":"2011","journal-title":"Chest"},{"issue":"13","key":"10.1378\/chest.12-1246_bib46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/hrt.2011.224857","article-title":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension","volume":"97","author":"Rhodes","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1378\/chest.12-1246_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.thromres.2011.03.004","article-title":"A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism","volume":"128","author":"Klok","year":"2011","journal-title":"Thromb Res"},{"key":"10.1378\/chest.12-1246_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-12-62","article-title":"GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells","volume":"12","author":"Nickel","year":"2011","journal-title":"Respir Res"},{"issue":"5","key":"10.1378\/chest.12-1246_bib49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/rccm.200802-235OC","article-title":"Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension","volume":"178","author":"Nickel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-1246_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1378\/chest.10-0302","article-title":"Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension","volume":"139","author":"Meadows","year":"2011","journal-title":"Chest"},{"issue":"12 suppl S","key":"10.1378\/chest.12-1246_bib51","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.12-1246_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/cs0960033","article-title":"Increased plasma levels of adrenomedullin in patients with pulmonary hypertension","volume":"96","author":"Kakishita","year":"1999","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1378\/chest.12-1246_bib53","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1152\/japplphysiol.90719.2008","article-title":"Elevated levels of activin A in clinical and experimental pulmonary hypertension","volume":"106","author":"Yndestad","year":"2009","journal-title":"J Appl Physiol"},{"issue":"9","key":"10.1378\/chest.12-1246_bib54","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1378\/chest.12-1246_bib55","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","article-title":"Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension","volume":"296","author":"Falc\u00e3o-Pires","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1378\/chest.12-1246_bib56","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.ATV.0000168414.06853.f0","article-title":"Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension","volume":"25","author":"Kielstein","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1378\/chest.12-1246_bib57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.200702-278OC","article-title":"Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension","volume":"176","author":"Skoro-Sajer","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1378\/chest.12-1246_bib58","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/ard.2007.080424","article-title":"Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension","volume":"67","author":"Iannone","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1378\/chest.12-1246_bib59","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00246-008-9374-1","article-title":"Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease","volume":"30","author":"Sungprem","year":"2009","journal-title":"Pediatr Cardiol"},{"issue":"18","key":"10.1378\/chest.12-1246_bib60","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/eurheartj\/ehq226","article-title":"Circulating angiopoietins in idiopathic pulmonary arterial hypertension","volume":"31","author":"K\u00fcmpers","year":"2010","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1378\/chest.12-1246_bib61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/1354750X.2010.492431","article-title":"Circulating biomarkers of tissue remodelling in pulmonary hypertension","volume":"15","author":"Schumann","year":"2010","journal-title":"Biomarkers"},{"issue":"9","key":"10.1378\/chest.12-1246_bib62","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.12-1246_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1536\/ihj.51.272","article-title":"Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension","volume":"51","author":"Hatano","year":"2010","journal-title":"Int Heart J"},{"issue":"11","key":"10.1378\/chest.12-1246_bib64","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1164\/rccm.200710-1458OC","article-title":"Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension","volume":"177","author":"Amabile","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.12-1246_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11239-010-0507-z","article-title":"Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension","volume":"31","author":"Diehl","year":"2011","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"10.1378\/chest.12-1246_bib66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.healun.2009.06.005","article-title":"Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients","volume":"28","author":"Amabile","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1378\/chest.12-1246_bib67","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.200706-840OC","article-title":"Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension","volume":"177","author":"Bakouboula","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-1246_bib68","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00246-010-9674-0","article-title":"Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease","volume":"31","author":"Smadja","year":"2010","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"10.1378\/chest.12-1246_bib69","first-page":"698","article-title":"Circulating endothelial cells in pulmonary hypertension","volume":"90","author":"Bull","year":"2003","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1378\/chest.12-1246_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCULATIONAHA.108.808246","article-title":"Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease","volume":"119","author":"Smadja","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1378\/chest.12-1246_bib71","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","article-title":"Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension","volume":"117","author":"Diller","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.12-1246_bib72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2353\/ajpath.2008.070705","article-title":"Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension","volume":"172","author":"Asosingh","year":"2008","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1378\/chest.12-1246_bib73","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.200810-1662OC","article-title":"Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension","volume":"180","author":"Toshner","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1378\/chest.12-1246_bib74","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.rmed.2007.12.030","article-title":"Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension","volume":"102","author":"JunHui","year":"2008","journal-title":"Respir Med"},{"issue":"9","key":"10.1378\/chest.12-1246_bib75","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.amjcard.2010.06.045","article-title":"Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease","volume":"106","author":"Yue","year":"2010","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1378\/chest.12-1246_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-010-9192-y","article-title":"Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension","volume":"14","author":"Smadja","year":"2011","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1378\/chest.12-1246_bib77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1538-7836.2006.01794.x","article-title":"Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol","volume":"4","author":"Woywodt","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:38:53Z","timestamp":1757918333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213604778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0012369213604778"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-1246","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-1246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}